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Abstract
Background: Schistosomiasis mansoni is a debilitating and sometimes fatal disease. Accurate diagnosis plays a key role in
patient management and infection control. However, currently available parasitological methods are laborious and lack
sensitivity. The selection of target antigen candidates has turned out to be a promising tool for the development of more
sensitive diagnostic methods. In our previous investigations, the use of crude antigens led to false-positive results. Recently,
focus has been given to highly purified Schistosoma mansoni antigens, especially to circulating antigens.
Method: Thus, our main goal was to test different types of circulating cathodic antigen glycoprotein (CCA), as ‘‘crude
antigen,’’ the protein chain of recombinant CCA and two individual peptides. These schistosome proteins/peptides were
tested in a new diagnostic method employing immunomagnetic separation based on the improvement of antigen–
antibody binding.
Principal Findings: Use of recombinant CCA as a diagnostic antigen allowed us to develop a diagnostic assay with high
sensitivity and specificity with no false-negative results. Interestingly, the ‘‘crude antigen’’ worked as a good marker for
control of cure after praziquantel treatment.
Conclusions/Significance: Our new diagnostic method was superior to enzyme-linked immunosorbent assay in diagnosing
low endemicity patients.
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Introduction
Schistosomiasis is a disease caused by one of six Schistosoma
species, namely Schistosoma haematobium, S. guineensis, S. intercalatum,
S. mansoni, S. japonicum, and S. mekongi [1]. Schistosomiasis occurs in
the tropics and subtropics and is among the most important
parasitic diseases worldwide, with a considerable socioeconomic
impact [2]. Seventy-four countries are endemic, with roughly 120
million individuals being symptomatically infected and 20 million
being severely affected [3]. Moreover, schistosomiasis represents
an increasing problem in non-endemic areas, due to the growing
number of immigrants and tourists [4–6]. Herein, diagnosis plays
a crucial role in the monitoring of early infection as well as efficacy
of treatment. Currently, the ‘gold’ standard remains the detection
of S. mansoni eggs in stools. The Kato-Katz technique is the most
widely used copromicroscopic method in epidemiological surveys
[7]. However, because of low and sporadic egg production, the risk
of having a large percentage of individuals who remain
undiagnosed is considerable. Undiagnosed individuals remain
infected and contribute to transmission of the disease [8,9].
Immunodiagnostic techniques are rapid, sensitive, convenient,
and easy to apply, and hence they have been used to estimate
infection rates with the goal of improving diagnosis in epidemi-
ological surveys and identifying individuals to target for treatment
[10–13]. Nonetheless, low specificity is frequently seen in
immunodiagnostic assays, largely due to the use of crude antigens
that contain many antigens that might be shared with unrelated
pathogens. The systematic purification of antigens from Schistosoma
spp. should allow the development of new anti-schistosome
antibodies that might become valuable diagnostic tools [14,15].
Antigens excreted by adult worms into the circulation of the host,
‘‘circulating antigens’’, have repeatedly been shown to be potent
diagnostic target molecules [16–19]. Research on circulating
antigens has focused on two genus-specific proteoglycan antigens
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derived from the schistosome gut: circulating anodic antigen
(CAA) and circulating cathodic antigen (CCA). Urine-dipstick
diagnostic tests that detect schistosome CCA have the potential to
provide more sensitive and rapid detection of for intestinal
schistosomiasis in field-based surveys and they showed promising
results in Africa [20], although the tests are currently not suitable
for rapid mapping of schistosomiasis in areas where S. mansoni and
S. haematobium are co-endemic [21].
For this reason, defined diagnostic antigen(s) that increase
sensitivity and specificity of serological assays and that can detect
patients with low parasite loads would be of considerable benefit to
schistosome control programs. In this regard, a new immunolog-
ical assay, immunomagnetic separation (IMS), was developed and
refined by our group. A benefit of this approach is to effectively
concentrate, rather than dilute, patient serum during incubation.
We compared IMS to enzyme-linked immunosorbent assay
(ELISA) using the same antigens in order to evaluate the
effectiveness of this new approach. Therefore we assessed the
sensitivity of different forms of CCA for their diagnostic potential.
The antigens we focused on were: (i) ‘‘crude antigen’’, (ii) protein
chain of recombinant CCA (CCAr), and (iii) two individual CCA
peptides (CCApep1 and CCApep2). A prospective survey was
performed with individuals from a low endemicity area for
schistosomiasis mansoni. Final analyses were done by comparing
IMS results to Kato-Katz and ‘‘Three Fecal Test’’ (TF-Test), as
parasitological assays.
Here, we show that a well standardized immunological assay is
sensitive and specific for the discrimination of low parasite load
cases, by demonstrating that (i) the levels of parasite-specific
immunoglobulin G (IgG) are significantly different from positive
and negative individuals when IMS is performed with CCAr; (ii)
IMS-CCAr achieved the most significant positivity ratio for
diagnosis with no false-negative results; and (iii) IMS methodology
was superior to ELISA in detecting the presence of schistosome
infection in patients with low parasite loads.
Methods
Ethics Statement
This project was approved by the Ethical Research Committee
of the Rene Rachou Research Center, Oswaldo Cruz Foundation
for Animal Use (CEUA L-0023/08) according to the International
Guiding Principles for Biomedical Research Involving Animals
developed by the Council for International Organizations of
Medical Sciences (CIOMS). The Ethical Research Committee of
the Rene Rachou Research Center (CEPSH/CPqRR 03/2008)
and the National Brazilian Ethical Board (784/2008, CONEP
14886) approved the human study. The study objectives were
presented and explained to all participants and written informed
consent was obtained through signing a form before admission to
this study. Parents/guardians provided written consent on behalf
of all child participants.
Community Survey
A prospective study was performed in the communities of Buriti
Seco and Morro Grande in Pedra Preta, a small village in a
schistosomiasis-endemic area in the rural region of Montes Claros,
Minas Gerais, southeast of Brazil [22]. This area was chosen based
on the fact that the population had not been treated for
schistosomiasis and also has a low population migration index.
Schistosomiasis prevalence rate of 12% was reported in 2005
according to data provided by the Montes Claros Zoonosis
Control Centre. The total amount of residents participating in the
survey was 201 individuals (93 females and 108 males).
Stool sample analysis. Four separate stool samples on four
consecutive days were provided for Kato-Katz thick smear
examination [7], with a total of 18 slides, prepared as follows for
each participant: 12 slides for the first sample and two slides each
for the second, third, and fourth samples. Hence, a total of 750 mg
of feces was examined per individual (18641.7 mg). The same
samples were analyzed by quantitative TF-Test as previously
described [22]. Briefly, samples were passed through a nylon mesh
and quantified in metal plates. Each 500 mg portion was
transferred to a tube with preservative solution (10% formalin)
and processed using ethyl acetate. Samples were centrifuged at
500 g for 2 min. The sediment was resuspended in 0.85% saline
solution and analyzed using optical microscopy [23].
Serum sample processing. Among the 201 individuals, 50
patients with parasite loads varying between 1 and 555 eggs per
gram of feces (EPG) were selected to provide serum samples (24
females and 26 males, aged 8–88 years). Individual serum samples
were obtained after centrifugation of blood samples at 3,000 g for
5 min and kept at 220uC.
Treatment of positive cases. Positive individuals were
treated with praziquantel in a single dose of 60 mg/kg for
children and 50 mg/kg for adults. Infections with other helminths
were treated with a single dose of 400 mg albendazole, as
recommended by the Brazilian Ministry of Health. Positive
patients submitted new stool and sera samples 30 days post-
treatment and were retreated.
Healthy Volunteers
Fifty-three healthy non-endemic area residents (35 females and
18 males, aged 22–65 years) were selected to be used as negative
control group. The volunteers presented no medical history of
previous schistosomiasis.
Confirmatory diagnosis of healthy donors. Confirmatory
diagnosis was performed using two ELISA assays for the detection
of IgG antibody against soluble worm antigen preparation
(ELISA-SWAP) and against soluble egg antigens (ELISA-SEA).
Patients reactive for both ELISA assays were removed from the
‘‘healthy’’ cohort.
CCA Preparation
‘‘Crude antigen’’ containing CCA glycoprotein. Adult
worms from S. mansoni (LE strain) were obtained by perfusion of
Author Summary
Schistosomiasis mansoni is a debilitating and sometimes
fatal disease that affects many individuals in Africa and
Brazil. Currently available diagnostic methods are not
sensitive for patients with low parasite load which leads to
underreported cases. The selection of target diagnostic
antigen candidates is a promising tool for the develop-
ment of a new and more sensitive assay. In this study, we
focused on different types of circulating cathodic antigen
(CCA) for development of an innovative assay. This new
assay is called immunomagnetic separation and it uses
magnetic microspheres attached to the antigens in order
to improve the diagnostic sensitivity. Best results were
found when we used the protein chain of the recombinant
CCA showing high sensitivity and specificity with no false-
negative results. Together, the use of ‘‘crude antigen’’
presented good results for the control of cure. Our new
assay was superior to enzyme-linked immunosorbent
assay in discriminating positive and negative cases,
especially related to patients with low parasite load.
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hepatic portal system of Swiss female mice (4–6 weeks) 45 days
post-infection with 100 cercariae [24]. Adult worms were
washed with 0.15 M phosphate buffer saline pH 7.2, submitted
to mechanical grinding (Virtiz Precisa; Dietikon, Switzerland)
and ultracentrifuged at 25,000 g for 1 h at 4uC (Sorvall;
Buckinghamshire, United Kingdom). Supernatant was heated
to 100uC for 30 min, as previously described [25] then filtered
through a 50 kDA exclusion filter (Millipore Amicon, Sigma-
Aldrich; St. Louis, United States of America). Final purified
product was dialyzed against saline solution 0.9% for 48 h at
4uC and maintained at 220uC prior to use, after protein
concentration analysis (Nanodrop, Thermo Scientific 2000;
Rockford, United States of America). A silver stained Tris-
glycine SDS-PAGE (12% gel) was performed to assess purity
[26].
CCAr. Adult worms were homogenized by glass homogenizer
with 1 ml of Trizol (Invitrogen; Grand Island, United States of
America), incubated for 10 min at 25uC when 200 ml of
chloroform was added. This suspension was centrifuged at
15,000 g for 15 min at 4uC and the upper layer was reserved.
RNA was precipitated by addition of 500 ml of isopropanol,
incubated for 10 min and centrifuged at 4uC for 10 min. Cold
75% ethanol was added to the pellet followed by a new
centrifugation step. Ethanol was removed and the final pellet
dried, ressuspended in RNase-free water and kept at 220uC until
use. cDNA was obtained according to the manufacturer’s
instructions (SuperScript II Reverse Transcriptase, Invitrogen;
Grand Island, United States of America).
CCA gene reference sequence was obtained from the database
of the National Center for Biotechnology Information (NCBI)
[27], GenBank AAB53003.1. To express the CCA domain, gene-
specific primers were designed as follows: sense 59- CCCGGATC-
CATGACGTTTGATTTCATGTTAAAG - 39 and antisense 59-
GGGCTCGAGTAGGGAGTTAATCATTTGATTCATAGC -
39 which contain BamHI and XHOI restriction sites (italicized),
respectively. The PCR conditions through 32 cycles were 95uC for
45 sec as denaturing step, 60uC for 45 sec as an annealing step
and 72uC for 1 min as an elongation step. The PCR product was
first subcloned into the pCR-Blunt II TOPO plasmid (Invitrogen;
Grand Island, United States of America) and transformed into
TOP10 competent cells. Recombinant plasmid DNA was isolated
and digested with the restriction enzymes. The resulting fragment
was purified and subcloned into BamHI-XhoI-cleaved pET21a.
The final recombinant expression plasmid (CCA-pET21a) was
sequenced and subsequently introduced into Escherichia coli strain
BL21 Gold competent cell (Agilent Technologies; La Jolla, United
States of America). Cells were grown overnight at 37uC in Luria
Bertani (LB)-medium containing 75 mg/ml ampicillin. The
overnight culture was diluted 100-fold in LB-medium and grown
until an optical density (OD) (600 nm) for 0.5 was reached. To
induce protein expression, isopropyl b-D-thiogalactoside (IPTG)
1.0 mM was added and the cells were grown for another 3 h. Cells
were harvested by centrifugation and sonicated. Purification was
done by affinity chromatography on His-Trap columns (Amer-
sham/Pharmacia; Pittsburgh, United States of America). The
homogeneity of the recombinant protein was analyzed by silver
stained Tris-glycine SDS-PAGE (12% gel) [26].
CCA peptides. CCA sequence was retrieved from NCBI/
protein and the full length protein sequence was subjected to B cell
prediction at BCPreds: B-cell epitope prediction server 1.0 [28–
30]. Two best conformations of surface exposed B cell epitope
sequences having the cut-off value for BCPreds (.0.9) were taken
into consideration. Peptides (Table 1) were synthesized (Mimo-
topes; San Diego, United States of America).
Purification evidence for CCA. A confirmation method was
used for each CCA antigen obtained. Microtiter plates MaxiSorp
Surface (NUNC, Thermo Scientific; Roskilde, Denmark) were
coated with 100 ml/well of 1 mg/ml of each antigen (‘‘crude
antigen’’, CCAr and each individual CCA peptide) diluted in 0.05
M carbonate-bicarbonate buffer pH 9.6 for 16 h at 4uC. As
positive controls, we included SWAP. Plates were washed three
times with 0.15 M phosphate buffered saline pH 7.2 with 0.05% of
Tween 20 (LGC Biotecnologia; Sa˜o Paulo, Brazil) (washing
buffer), then blocked by incubation with 2.5% skim milk at
37uC for 1 h. Then, 100 ml/well of a peroxidase conjugated IgG1
monoclonal antibody against CCA was added (1:8,000) (lot
5F4.B4, University of Georgia, Monoclonal Antibody Facility;
Athens, United States of America) then incubated at RT for 1 h.
Plates were washed in PBS-T 0.05%, then 100 ml of substrate
3,39,5,5-tetramethylbenzidine solution (Invitrogen; Grand Island,
United States of America) were added and the reaction stopped
after 15 min of incubation by addition of 50 ml/well of 2 N sulfuric
acid. Results were obtained as OD at 450 nm using a microplate
reader (Model 3550, Bio-Rad Laboratories; Tokyo, Japan).
IMS with CCA
Paramagnetic microspheres (0.4 mm) (Estapor Microspheres,
Merck; Lyon, France) were sensitized with CCA (106 microspheres
with 1 mg/ml of antigen/assay): (i) with ‘‘crude antigen’’; (ii)
CCAr; (iii) CCA pep1; and (iv) CCA pep2. All incubation steps
were performed under rotation to improve antigen-antibody
binding. For sensitization step, antigens were diluted in 0.05 M
carbonate-bicarbonate buffer pH 9.6 for 16 h at 4uC. Micro-
spheres were washed four times with washing buffer using a 1.5 ml
tube magnetic base (Invitrogen; Grand Island, United States of
America). Non specific-binding was blocked using 20% skim milk
proteins in washing buffer at 4uC for 16 h. Microspheres were
washed and maintained at 4uC. Prior to use, microspheres were
washed, then 100 ml of a non-diluted serum sample were added in
duplicate, followed by incubation at 37uC for 1 h. Microspheres
were then incubated at 37uC for 1 h with 100 ml of peroxidase
conjugated anti-human IgG Fc specific (Sigma-Aldrich; St. Louis,
United States of America) diluted 1:60,000 in washing buffer.
Tubes were washed and 100 ml of substrate 3,39,5,5-tetramethyl-
benzidine solution (TMB/H2O2) (Invitrogen; Grand Island,
United States of America) were added to each well and the
reaction was stopped after 10 min. Using the magnetic base,
supernatant were transferred to a microtiter plate and results were
obtained as OD at 450 nm in a microplate reader (Model 3550,
Bio-Rad Laboratories; Tokyo, Japan).
Indirect ELISA with CCA
ELISA were standardized based on a technique described
elsewhere [31] after some modifications. Microtiter plates Max-
iSorp Surface (NUNC, Thermo Scientific; Roskilde, Denmark)
were coated with 100 ml per well of CCA diluted at 1 ml/ml in
0.05 M carbonate-bicarbonate buffer pH 9.6 for 16 h at 4uC.
Plates were washed three times, then blocked by addition of 2.5%
skim milk and incubating at 37uC for 1 h. Plates were washed,
then 100 ml of individual serum sample diluted 1:100 in 0.15 M
phosphate buffer saline pH 7.2 were added in duplicate followed
by incubation for 1 h. Plates were then washed and incubated with
peroxidase conjugated anti-human IgG Fc specific (Sigma-Aldrich;
St. Louis, United States of America) diluted in washing buffer at
1:60,000. 100 ml of substrate solution were added to each well and
the reaction was stopped after 10 min of incubation and OD at
450 nm determined by microplate reader. The cut-off value of
each ELISA method was determined by receiver operating curve
Target Antigens for Schistosomiasis Diagnosis
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(ROC) and they were defined as 0.250 for ELISA-crude Ag, 0.103
for ELISA-CCAr, 0.117 for ELISA-CCApep1 and, 0.166 for
ELISA-CCApep2 (A= 0.765, 0.924, 0.954, 0.824, respectively).
Positive and negative controls were assayed for both techniques.
Statistical Analysis
Data derived from absorbance values were analyzed with
Minitab software (Minitab Inc, United States of America) by
Kolmogorov-Smirnov normality test. Normal distributed data
were analyzed by Student’s t test and non-normal distributed data
were analyzed by Mann-Whitney test. Comparisons between
methods were done by chi-square (x2) analysis (p,0.05 as
significance level). The sensitivity, specificity, cut-off values, and
likelihood ratios were determined with Prism 4.0 software.
Agreement between methods was measured using the Cohen
coefficient [32] and analyzed according the Landis & Koch
definition [33], with software ComKappa 2.0: 1.00-0.81 almost
perfect agreement; 0.80-0.61 substantial agreement; 0.60-0.41
moderate agreement; 0.40-0.21 fair agreement; 0.20-0 slight
agreement; ,0 poor agreement.
Accession Numbers
CCA gene reference sequence was obtained from the database
of the National Center for Biotechnology Information (NCBI),
GenBank AAB53003.1.
Results
CCA Preparation
Four different forms of CCA were obtained and tested in IMS
assays. Initially, the ‘‘crude antigen’’ was obtained from adult
worm extracts and the CCAr were induced in E. coli. Final
products are shown on Figure 1 and both demonstrated a 30 kDa
protein, correlating with previously reported characteristics of
CCA [25].
Afterwards, two CCA peptides were synthesized based on
predicted B cell epitopes. These four CCA were then tested as
diagnostic assay candidates, using a monoclonal IgG1 antibody
against S. mansoni CCA (lot 5F4.B4, University of Georgia,
Monoclonal Antibody Facility, Athens, United States of America).
Results are shown on Figure 2 where a significant reaction was
seen for all four CCA in comparison to bovine serum albumin
(BSA) as our negative control.
IMS Validation for Low Endemicity Area Residents
The prospective study involved the communities of Buriti Seco
and Morro Grande in Pedra Preta, southeast Brazil. These
communities are areas of low endemicity for schistosomiasis
mansoni, and with low migration index and no history of previous
treatment. Among the 201 individuals participating in the survey,
50 patients including adults and children were selected to provide
serum samples (24 females and 26 males). These patients were first
diagnosed by Kato-Katz and TF-Test and results showed a
parasite load range between 1 and 555 EPG among the group. All
patients were treated as recommended and they resubmitted stools
for Kato-Katz testing 30 days post treatment when serum samples
were obtained. Retreatment was done in all reinfection cases.
The 50 serum samples selected from people of Pedra Preta,
together with the healthy donors’ serum samples were screened by
IMS using the four different antigens described: sensitized with
‘‘crude antigen’’ (IMS-crude Ag), CCAr (IMS-CCAr), CCA pep1
and CCApep2 (IMS-CCApep1 and IMS-CCApep2). The 53
healthy donors were initially tested for antibodies to schistosomes
by ELISA-SWAP and ELISA-SEA. Only one individual was
reactive for both antigens and was not therefore removed from the
healthy (negative) control group. Further, cut-off value, positivity
ratio, sensitivity, and specificity of each IMS methodology were
determined by ROC, which are represented in Figure 3.
IMS-crude Ag presented a sensitivity of 90% and a specificity of
92% for a cut-off value of 0.197, which showed that the ‘‘crude
antigen’’ might be considered a good marker for schistosome
infection with five missing positive patients and four missing
negative individuals. Moreover, IMS using CCAr showed an
excellent result providing a sensitivity of 100% and specificity of
Table 1. Predicted B cell epitopes for Schistosoma mansoni CCA.
Reference no. Peptide sequence Amino acid positions BCPred score
1 Pro-Asn-Pro-Ser-Asp-Asp-Ser-Ser-Asn-Ser-Gly-Thr-Ile-Ser-Gly-Asn-His-Ser-Asp-Glu 307 1
2 Lys-Gln-Leu-Glu-Gln-Leu-Lys-Ile-Glu-Asn-Lys-Thr-Leu-Arg-Asn-Ser-Leu-Asp-Glu-His 83 0.93
doi:10.1371/journal.pntd.0002054.t001
Figure 1. SDS-PAGE analysis of the ‘‘crude antigen’’ and the
protein chain of recombinant CCA. Aliquots of samples corre-
sponding to the final product of adult worm extract submitted to
purification steps (2) and, the CCA recombinant protein expressed in E.
coli before (3) and after (4) induction with IPTG were subjected to silver
stained SDS-PAGE analysis. Electrophoresis was done using 12% Tris-
glycine gels. Molecular weight standards are shown in (1).
doi:10.1371/journal.pntd.0002054.g001
Target Antigens for Schistosomiasis Diagnosis
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96% for a cut-off of 0.063, where only two negative individuals
presented false-positive results. Finally, IMS using CCA peptides
showed similar effectiveness with the same sensitivity (80%) and a
specificity of 90% and 92%, respectively for cut-off values of 0.164
and 0.133. When analyzing false-positive and false-negative
results, we could see that the use of these 20 amino acids peptides
decreased the diagnostic effectiveness with 10 false-negative results
for both peptides, five for IMS-CCApep1, and four for IMS-
CCApep2. The positivity ratios achieved by each IMS method
were 91% (93/102), 98% (100/102), 85% (87/102) and 86% (88/
102), for IMS-crude Ag, IMS-CCAr, IMS-CCApep1 and IMS-
CCApep2, respectively. The positivity ratio achieved by IMS-
CCAr was significantly higher than the other three IMS assays
(x2 = 0.74, p,0.05). Figure 4 shows the individual OD for each
positive and negative patient as determined by each IMS protocol.
Not all the infected patients showed an adequate post treatment
follow-up, since no eggs were found in any patient stools 30 days
after drug administration. Forty-two of the 50 praziquantel-treated
patients agreed to donate serum samples once more. Diagnostic
results obtained by the four IMS protocols from both time points
were compared with the purpose of detecting any differences in
IgG antibody titers. From the observations in each period, 98% of
the patients became negative via IMS-crude Ag (41/42), whereas
81% became negative via IMS-CCApep1 (34/42) and 93% via
IMS-CCApep2 (39/42). IMS using CCAr identified 55% of the
patients as negative for S. mansoni 30 days after treatment (23/42),
as shown in Figure 5.
Comparative Analysis of the Effectiveness of IMS with
ELISA
In addition to the fact that IMS was standardized with non-
diluted serum, the incubation steps were performed under rotation
with the purpose of improving antigen-antibody binding and thus,
diagnostic sensitivity. To test this hypothesis, ‘‘crude antigen’’,
CCAr, and CCA peptides were used in ELISA (ELISA-crude Ag,
ELISA-CCAr, ELISA-CCApep1, and ELISA-CCApep2) and the
results were compared to data obtained using IMS analysis.
Significant differences were observed in the positivity ratios. Forty-
five positive patients were correctly diagnosed by IMS-crude Ag,
but only 35 were diagnosed by ELISA-crude Ag (x2 = 0.21,
p,0.05). All the patients were positive for IMS-CCAr in
comparison to 48 patients diagnosed by ELISA-CCAr
(x2 = 0.48, p,0.05). On the other hand, IMS-CCApep1 and
ELISA-CCApep1 presented no difference with 40 positive
patients. However, comparing CCApep2, statistical differences
were detected with 40 patients diagnosed by IMS-CCApep2 and
37 by ELISA-CCApep2 (x2 = 0.21, p,0.05). Analysis of Cohen’s
kappa index showed a moderate agreement of 0.47 (60.10) (69/
102) between IMS-crude Ag and ELISA-crude Ag. The same
agreement was found for IMS-CCApep2 and ELISA-CCApep2
that showed an agreement of 0.48 (60.11) (66/102). A better
agreement was found for IMS-CCAr versus ELISA-CCAr and,
IMS-CCApep1 versus ELISA-CCApep1, which indicated a sub-
stantial agreement of 0.66 (60.10) with a positivity of 84/102 and
0.70 (60.11) with 75/102, respectively.
Figure 2. Binding of CCA-specific monoclonal IgG1 antibody to the four CCA antigens. Antigens represented by bars are: SWAP – soluble
worm antigen preparation, as the positive control; ‘‘crude antigen’’; protein chain of recombinant CCA; CCA peptides 1 (BCPred Score = 1) and 2
(BCPred Score = 0.926). Each OD value is representative for the mean of four absorbance values. Statistical differences for comparisons done to BSA
are represented by *** (p,0.05) using Student’s t test. Artwork created by Prism 5.0 software.
doi:10.1371/journal.pntd.0002054.g002
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Data obtained from a prospective parasitological diagnosis with
18 slides of Kato-Katz plus TF-Test confirmed the low parasite
load of residents of Pedra Preta that were infected by S. mansoni (1
to 555 EPG). Based on the World Health Organization thresholds
[34], most of the infected individuals (48/50) presented low
parasite load (1–99 EPG). Hence, those individuals were
subdivided into three groups: 1–10 EPG, 11–30 EPG, and .30
EPG in order to determine the sensitivity of each methodology
used. Groups were examined by IMS and ELISA methods.
Results are shown in Table 2.
Discussion
Population and treatment-based control programs have been
successful in reducing the intensity of infection and severe
morbidities associated with schistosomiasis. However, transmis-
sion remains active in highly endemic areas, and recurring low-
level reinfection is likely to be associated with subtle but
persistent morbidities [35–37]. Adequate case-finding is essen-
tial for the effective execution of control programs. Diagnosis
has mainly depended upon finding eggs in patients’ fecal
samples. However, fluctuation in egg output and the chance of
missing light infections necessitate repeated examinations [9].
Serologic testing has been used to enhance our ability to detect
the disease in order to be more sensitive in demonstrating light
infections [10–12,38]. This study applied a multievaluation
approach, combining specific antibody detection for four
different antigens with an investigation performed on parasito-
logical data in efforts to produce a more field-applicable assay
format.
The identification and description of CCA as a constitutional
glycoprotein from adult worms gut [39] has allowed the
development of assays for detecting antibodies or circulating
antigens in urine and serum samples of infected individuals
[18,19,40–42]. When CCA was used in those assays, sensitivity
was lower than expected which was partly explained as a
consequence of low levels of circulating antigens being regurgitat-
ed by adult worms [43], especially in patients with low parasite
loads. To solve this problem, we standardized a method called
IMS that uses paramagnetic beads in contact with non-diluted
serum and is based on incubation steps performed under rotation,
allowing an increased antigen-antibody binding. The IMS method
was evaluated with four different CCA, including the ‘‘crude
antigen’’, the protein chain of CCAr and, also, two individual
peptides of 20 amino acids. Since schistosomiasis epidemiological
profiles show an increase in the number of low endemicity areas,
the sensitivity of each IMS was validated with patients’ samples
from an endemic area in southeast Brazil, where most of them
showed low parasite load based on 18 Kato-Katz thick smears plus
TF-Test.
Although ‘‘crude antigen’’ prepared from S. mansoni adult worm
showed good results in IMS-crude Ag methodology, CCAr
presented more significant results, especially when all the positive
cases were properly detected with a sensitivity of 100% and, only
two false-positive results, giving rise to a specificity of 96%
(x2 = 0.74, p,0.05). Whereas IMS-crude Ag achieved 90%
sensitivity and 92% specificity, with five false-negative and four
false-positive results.
Comparison between the positivity ratios revealed that IMS-
CCAr was significantly superior to IMS-crude Ag for diagnosing
Figure 3. ROC curves of each IMS protocol. In (a) IMS-crude Ag (A= 0.97, p,0.05); (b) IMS-CCAr (A = 0.99, p,0.05); (c) IMS-CCApep1 (A= 0.90,
p,0.05); and (d) IMS-CCApep2 (A= 0.94, p,0.05). Artwork created by Prism 5.0 software.
doi:10.1371/journal.pntd.0002054.g003
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low endemicity patients (x2 = 0.74, p,0.05). The prior structural
difference between ‘‘crude antigen’’ and CCAr that justifies their
specificity lays on the fact that CCA is present in ‘‘crude antigen’’
sample in its native form as a whole glycoprotein, while the
recombinant CCA was expressed in E. coli and contains only the
protein chain of the native CCA, which was not glycosylated.
Native CCA glycoprotein contains 0-linked poly (Lex) carbohy-
drate chains with approximately 25 repeating units. Carbohydrate
chains containing multiple Lex determinants have been identified
on several glycolipids not only from schistosomes but also from
other parasites [44,45], from human adenocarcinomas [46] and
also, circulating granulocytes carry relatively high abundance of
branched N-linked polysaccharides having Lex repeating units
[47,48]. Additionally, Lex sequence is particularly immunogenic,
playing an important role during inflammatory processes,
especially in granulocyte and monocyte adhesion processes and
recruiting granulocytes to sites of inflammation [49]. It is
conceivable that the use of the native CCA glycoprotein in
schistosome diagnosis leads to false-positive results, when IgG
antibodies against its most immunogenic portion (the Lex units)
can be mistakenly detected. In contrast, the CCA protein sequence
of 347 amino acids, obtained by recombinant expression, is
exclusively found in the genus Schistosoma with no description in
any other parasite or human proteins, confirmed by Blast search.
The use of synthetic peptides corresponding to a single
continuous epitope may increase the specificity of an immunoassay
in the same way that monoclonal antibodies recognizing a single
epitope do compared to polyclonal antiserum. Thus prediction of
B cell epitopes was performed and the two best conformations
were considered. Same identity analysis was done and both
peptides were recognized by the CCA-specific monoclonal
antibody. When evaluating each peptide for the diagnosis of S.
mansoni using IMS methodology, data showed similar results for
these two methods, as demonstrated by ROC. IMS-CCApep1
presented 80% of sensitivity and 90% of specificity with 10 missing
positive cases and five missing negative individuals. IMS-
CCApep2 showed the same sensitivity and four missing negative
cases, leading to a specificity of 80%. Despite the possible
advantage of increasing diagnosis specificity with individual
peptides, our data did not show any disparity in specificity
between IMS-crude Ag and IMS-CCApep1 or IMS-CCApep2
when similar identification of false-positive cases was found by the
three methods.
In a final comparison of the four antigens, CCAr continued to
yield a higher positivity ratio of 98% compared to ‘‘crude antigen’’
(91%), CCApep1 (85%), and CCApep2 (86%) (x2 = 0.74, p,0.05).
Recombinant protein-based diagnosis offers important advantages
because higher antigen concentrations can be used, and nonspe-
cific moieties are not present in those proteins, as they may be in
crude antigens or in native proteins. Nevertheless, due to the
restricted amino acids sequence of a single peptide, the use of each
sequence has been deemed impractical. This suggests that for
Figure 4. Individual analysis of 102 serum samples by the IMS protocols. Each OD value is representative for the mean of four absorbance
values. Cut-off values are represented by bars. In (a) IMS-crude Ag (cut-off = 0.20); (b) IMS-CCAr (cut-off = 0.06); (c) IMS-CCApep1 (cut-off = 0.16); and
(d) IMS-CCApep2 (cut-off = 0.13). Artwork created by Prism 5.0 software.
doi:10.1371/journal.pntd.0002054.g004
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peptides to be used a large pool of epitopes would be required to
achieve wide population coverage and the cost would increase
significantly.
All the individuals who presented eggs in stools were treated, as
recommended by the Brazilian Ministry of Health. These positive
patients were invited to resubmit stool samples subjected to the
Kato-Katz technique after 30 days of chemotherapy and none of
them presented eggs in stool at that time. Forty-two patients were
followed up by IMS methodology. A decrease was detected on IgG
antibody level for some individuals in the four IMS assays. Forty-
one patients presented low IgG levels for IMS-crude Ag, whereas
only 23 presented for IMS-CCAr, 34 for IMSCCApep1, and 39
for IMS-CCApep2. Although the dynamics of the post-treatment
antibody levels are variable [50], IMS-crude Ag, IMS-CCApep1,
and IMS-CCApep2 results were considered extreme. The analysis
of the control of cure of IMS-CCAr would benefit from patients’
diagnosis in different time points for at least one year. The
establishment of antibody titers timeline may help to distinguish
the treatments that result in parasitological cure from those that
are only partially successful.
The distinctive patient who was positive for IMS-crude Ag was
also positive for the other IMS methodologies showing no
inconsistency on the diagnosis performed for IMS. The possibility
that this patient may have been reinfected or presented immature
Figure 5. Individual analysis of IgG titer in 30 days after praziquantel administration by IMS protocols. Each OD value is representative
for the mean of four absorbance values. Cut-off values are represented by bars. In: (a) IMS-crude Ag; (b) IMS-CCAr; (c) IMS-CCApep1; and (d) IMS-
CCApep2. Artwork created by Prism 5.0 software.
doi:10.1371/journal.pntd.0002054.g005
Table 2. Relation between the number of eggs and IMS and ELISA diagnosis.
Number of eggs per
gram of feces (EPG) n Positive results detected by each method
IMS-crude
Ag
IMS-
CCAr
IMS-
CCApep1
IMS-
CCApep2
ELISA-
crude Ag
ELISA-
CCAr
ELISA-
CCApep1 ELISA-CCApep2
1–10 30 26 30 23 24 18 29 24 19
11–30 11 11 11 11 8 8 10 8 9
.30 9 8 9 6 8 9 9 8 9
doi:10.1371/journal.pntd.0002054.t002
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worms at the moment of treatment cannot be excluded. No data
involving the detection of CCA in serum of patients infected for
less than 6 weeks have been published to date. However, CCA can
be detected in mice 3 weeks post-infection, plus freshly
transformed schistosomula, or isolated adult worms excrete CCA
in vitro immediately after transformation [51].
Since other investigators have reported low sensitivity values for
the detection of antibodies against CCA or the circulating antigen
itself in urine and serum samples using immunological assays for S.
mansoni diagnosis [19,41,42,52], we compared our IMS data with
results obtained by ELISAs that were standardized with the same
CCA antigens. The main differences of these two methodologies
were: (i) IMS was performed with non-diluted serum, while ELISA
used only diluted samples (1:100), and (ii) incubation steps were
done under rotation for IMS, different from the ELISA. As
expected, the use of ‘‘crude antigen’’, CCAr, and CCApep2 on
IMS methodology showed significant higher sensitivity than
ELISAs. Indeed, IMS-crude Ag were capable of detecting 10
extra positive patients than ELISA-crude Ag (x2 = 0.21, p,0.05),
whereas IMS-CCAr and IMS-CCApep2 detected two and three
extras positive patients, respectively than ELISAs (x2 = 0.48 and
0.21, p,0.05). The superiority of IMS in detecting positive cases
was evident when low egg burden patients were divided into three
groups based on parasite load. Interestingly, our data showed that
IMS-crude Ag, IMS-CCAr and IMS-CCApep2 continued to show
a higher sensitivity than ELISA even for patients with parasite
loads as low as 1–10 EPG, and this observation was especially
demonstrated by IMS-CCAr. Cohen’s kappa index confirmed a
moderate agreement between IMS and ELISA for CCA ‘‘crude
antigen’’ (0.4760.10) and CCApep2 (0.4860.11), and a substan-
tial agreement for CCAr (0.6660.10) and CCApep1 (0.7060.11).
The present study was undertaken to develop an assay that
might be more field applicable than the ELISA for testing of
individuals from low endemicity areas. The comparison between
different types of CCA allowed the evaluation of the specific
capability of each assay in diagnosing positive and negative
individuals and the occurrence of false-positive and/or false-
negative results. IMS-CCAr presented the most significant
positivity ratio for the primary diagnosis. Due to the restricted
single epitopes of individual peptides, the 20 amino acids sequence
used here showed no advantages in comparison to other antigens.
Results revealed that the detection of specific IgG antibody against
CCA antigens in serum may be used as an important tool for the
diagnosis of S. mansoni for patients with low parasite load.
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